Uniphar (UPR.I, UPR ID)

  • 830.0
  • 273.0
  • 78.0
  • UNIPHAR

    Closing Price (c): 304.0

  • RATING 27/08/19

  • PREVIOUS RATING

Company Profile

Uniphar is a diversified healthcare services business operating across three divisions: Commercial & Clinical (47% of group EBITDA 2022E), Product Access (19%) and Supply Chain & Retail (34%). Structural industry growth, proprietary digital platforms and expansion into new geographies underpin a strong organic growth outlook. There is also meaningful scope for bolt-on M&A, supported by a senior leadership team with deep experience across the healthcare services space. Management aims to double group EBITDA within five years (15% CAGR).


Major Shareholders%
ROI Health8.9
Sisk Family7.2
Allianz Global Investors7.1
Polar Capital LLP7.0
MacKenzie Financial Corp6.4